CN113456755A - 一种用于治疗皮肤瘙痒的药膏及其制备方法 - Google Patents
一种用于治疗皮肤瘙痒的药膏及其制备方法 Download PDFInfo
- Publication number
- CN113456755A CN113456755A CN202110665243.7A CN202110665243A CN113456755A CN 113456755 A CN113456755 A CN 113456755A CN 202110665243 A CN202110665243 A CN 202110665243A CN 113456755 A CN113456755 A CN 113456755A
- Authority
- CN
- China
- Prior art keywords
- parts
- formula
- ointment
- raw materials
- following raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 51
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 36
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 27
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 27
- 239000011593 sulfur Substances 0.000 claims abstract description 27
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 26
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 24
- 229940037003 alum Drugs 0.000 claims abstract description 23
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 21
- 240000000275 Persicaria hydropiper Species 0.000 claims abstract description 21
- 235000017337 Persicaria hydropiper Nutrition 0.000 claims abstract description 21
- 229940041616 menthol Drugs 0.000 claims abstract description 21
- 240000008086 Echinocereus enneacanthus Species 0.000 claims abstract description 20
- 235000010837 Echinocereus enneacanthus subsp brevispinus Nutrition 0.000 claims abstract description 20
- 235000006850 Echinocereus enneacanthus var dubius Nutrition 0.000 claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 18
- 239000010776 emu oil Substances 0.000 claims abstract description 15
- -1 dried alum Chemical compound 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims description 36
- 238000002156 mixing Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 238000004140 cleaning Methods 0.000 claims description 12
- 238000010411 cooking Methods 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 210000003899 penis Anatomy 0.000 claims description 7
- 238000007605 air drying Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 238000010025 steaming Methods 0.000 claims description 6
- 210000001550 testis Anatomy 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 208000017520 skin disease Diseases 0.000 abstract description 10
- 208000002474 Tinea Diseases 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010005913 Body tinea Diseases 0.000 abstract description 4
- 201000009053 Neurodermatitis Diseases 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 201000004681 Psoriasis Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 201000003875 tinea corporis Diseases 0.000 abstract description 4
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 19
- 230000007803 itching Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000272534 Struthio camelus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Abstract
本发明公开了一种用于治疗皮肤瘙痒的药膏及其制备方法,由A方、B方与鸸鹋油组成,所述A方至少由以下原料组成:金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙,所述B方至少由以下原料组成:硫磺、枯矾、信石、薄荷脑;所述A方至少由以下重量份的原料组成:金银花根25‑40份、苦参15‑30份、蛇床子10‑20份、白及15‑30份、艾叶8‑20份、霸王鞭5‑15份、刺蓼8‑16份、古山龙5‑15份;本发明所提供的药膏,其通过在配方中使用多种中药,具备解毒、利湿、祛风等功效,能够有效的缓解皮肤瘙痒,对于银屑病、神经皮炎、体癣等皮肤病具备良好的疗效,痊愈率高,且停药后复发率低,使用效果好。
Description
技术领域
本发明涉及一种止痒药膏,具体是一种用于治疗皮肤瘙痒的药膏及其制备方法。
背景技术
皮肤病是皮肤受到内外因素的影响后,其形态、结构和功能发生变化,产生病理的过程,并相应的产生各种临床表现。皮肤病是严重影响人民健康的常见病、多发病之一,皮肤病的发病率很高,多比较轻,常不影响健康,但少数较重病症可以危及生命。
因皮肤作为人体的第一道生理防线和最大的器官,时刻参与机体的功能活动,维持着机体和自然环境的对立统一,机体内部的任何异常情况也可以在皮肤表面,反映出来。很多皮肤病与细胞分裂异常、致病微生物感染及其产生的毒素、机体代谢紊乱、免疫功能失衡、内分泌紊乱、自由基毒素代谢障碍,甚至与精神、神经系统的病理变化有着间接或直接的关系,皮肤瘙痒作为一种皮肤病及各种皮肤病的并发症,往往给患者造成了难以忍受的煎熬。
现有的用于治疗皮肤瘙痒的药膏,大多只作用于皮肤表面,通过配方中添加的薄荷及冰片等成分,刺激皮肤神经末梢感受器,使其先产生清凉的感觉,再有轻微的灼热感,继而引起该皮肤处的毛细血管充血,以达到止痒和止痛的效果,但此类药膏往往是治标不治本,当停药一段时间后,皮肤又会逐渐产生瘙痒,使用效果不佳。
发明内容
本发明的目的在于提供一种用于治疗皮肤瘙痒的药膏及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
本发明的第一方面提供了一种用于治疗皮肤瘙痒的药膏及其制备方法,由A方、B方与鸸鹋油组成,所述A方至少由以下原料组成:金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙,所述B方至少由以下原料组成:硫磺、枯矾、信石、薄荷脑。
作为本发明进一步的方案:所述A方至少由以下重量份的原料组成:金银花根25-40份、苦参15-30份、蛇床子10-20份、白及15-30份、艾叶8-20份、霸王鞭5-15份、刺蓼8-16份、古山龙5-15份,所述B方至少由以下重量份的原料组成:硫磺5-15份、枯矾5-15份、信石3-8份、薄荷脑5-20份。
作为本发明进一步的方案:所述A方至少由以下重量份的原料组成:金银花根28-36份、苦参18-25份、蛇床子12-18份、白及17-24份、艾叶10-16份、霸王鞭6-13份、刺蓼8-14份、古山龙7-12份,所述B方至少由以下重量份的原料组成:硫磺6-13份、枯矾5-10份、信石3-6份、薄荷脑5-18份。
作为本发明进一步的方案:所述A方至少由以下重量份的原料组成:金银花根31份、苦参19份、蛇床子14份、白及19份、艾叶13份、霸王鞭9份、刺蓼11份、古山龙8份,所述B方至少由以下重量份的原料组成:硫磺9份、枯矾7份、信石3份、薄荷脑14份。
作为本发明再进一步的方案:所述A方至少由以下重量份的原料组成:金银花根33份、苦参20份、蛇床子12份、白及19份、艾叶15份、霸王鞭11份、刺蓼9份、古山龙11份,所述B方至少由以下重量份的原料组成:硫磺10份、枯矾5份、信石5份、薄荷脑17份。
本发明的第二方面提供了上述用于治疗皮肤瘙痒的药膏的制备方法,包括以下步骤:
步骤一:按配方量称取A方与B方的原料,分别放置备用;
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水蒸煮0.5-1.0h后,过滤得到药渣和药液A;
步骤四:在压力容器中将药渣与水混合,蒸煮0.5-1.0h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
作为本发明再进一步的方案:步骤三中,蒸煮前压力容器内的物料固液比为1:5-8,蒸煮过程中,压力容器内水的沸点为115-125℃。
作为本发明再进一步的方案:步骤四中,蒸煮前压力容器内的物料固液比为1:4-6,蒸煮过程中,压力容器内水的沸点为115-125℃。
作为本发明再进一步的方案:步骤六中,药粉的粒径为研磨至不大于180目,且95%的药粉粒径小于200目。
与现有技术相比,本发明的有益效果是:
本发明所提供的药膏,其通过在配方中使用多种中药,具备解毒、利湿、祛风等功效,能够有效的缓解皮肤瘙痒,对于银屑病、神经皮炎、体癣等皮肤病具备良好的疗效,痊愈率高,且停药后复发率低,使用效果好。
具体实施方式
为了使本发明所要解决的技术问题、技术方案及有益效果更加清楚明白,以下将结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明的第一方面提供了一种用于治疗皮肤瘙痒的药膏及其制备方法,由A方、B方与鸸鹋油组成,所述A方至少由以下原料组成:金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙,所述B方至少由以下原料组成:硫磺、枯矾、信石、薄荷脑。
金银花根具有清热解毒的功效,可用于皮肤生疮、皮肤瘙痒,用金银花根泡水喝上几天慢慢就能有所缓解。而且金银花根可以清肝明目,缓解咽喉肿痛,口腔溃疡。金银花根还可以抗炎杀菌,这个作用也已经被用于抗菌药物的制作。
苦参,为豆科植物苦参的干燥根,春、秋二季采挖,除去根头和小支根,洗净,干燥,或趁鲜切片,干燥。其苦,寒。有清热燥湿,杀虫,利尿之功。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风。
硫磺,味酸,性温,外治用于疥癣,秃疮,阴疽恶疮。
枯矾,又名煅白矾,取拣净的白矾,置砂锅内加热溶化并煅至枯干,取出,为不规则的结晶体,大小不一,无色,透明或半透明,表面略平滑或凹凸不平,具细密纵棱,有玻璃样光泽。质硬而脆,易砸碎,气微,味微甜而涩,以色白、透明、质硬而脆、无杂质者为佳,消痰,燥湿,止泻,止血,解毒,杀虫。治癫痫,喉痹,疚涎壅甚,肝炎,黄疸,黄肿,胃、十二指肠溃疡,子宫脱垂,白带,泻痢,衄血,口舌生疮,疮痔疥癣,水、火、虫伤。
蛇床子具有燥湿祛风,杀虫止痒,温肾壮阳等功效。主治阴痒带下,湿疹瘙痒,湿痹腰痛,肾虚阳痿,宫冷不孕。
白及,每年9~10月当茎叶枯萎时采挖,除去须根,洗净,置沸水中煮或蒸至无白心,晒至半干,除去外皮,晒干苦、甘、涩,微寒,具有收敛止血,消肿生肌等功效,用于咯血,吐血,外伤出血,疮疡肿毒,皮肤皲裂。
薄荷脑,也叫薄荷醇是一种有机化合物,其在医药上用作刺激药,作用于皮肤或粘膜,有清凉止痒作用。
艾叶用于少腹冷痛,经寒不调,宫冷不孕,吐血,衄血,崩漏经多,妊娠下血;外治皮肤瘙痒。
霸王鞭,性味微苦、涩,平。具有祛风消炎的功效。能治疮疡肿毒,皮癣。
刺蓼,具有解毒消肿,利湿止痒等功效。用于湿疹,黄水疮,疔疮,痈疖,蛇咬伤。
古山龙,性味苦,寒。具有清热利湿,解毒止痛等功效。用于预防流行性感冒、钩端螺旋体病,治急性胃肠炎,细菌性痢疾,扁桃体炎,支气管炎,疟疾;外用治眼结膜炎,皮肤湿疹,脓疱疮,阴道炎。
鸸鹋油又称澳洲鸵鸟油,它的非凡功效来源于纯鸸鹋油的强大的消炎功能以及出色的肌肤渗透性;进一步的研究证明,纯鸸鹋油中不饱和脂肪酸高达70%,其中单体不饱和脂肪酸占总脂肪酸量的40%,还含有Omega(欧米茄)3,6,7,9.这些脂肪酸的构成比例在生物界中绝无仅有,是最适合人体吸收,最接近人体皮肤油脂的纯天然成分,因此渗透能力超群,能将上述必需脂肪酸和其天然包含的维他命A,D,E,F,K2携带吸收进入人体,通过将鸸鹋油加入至中药药膏中,能够有效的提高药膏内药物成分的吸收效果。
所述A方至少由以下重量份的原料组成:金银花根25-40份、苦参15-30份、蛇床子10-20份、白及15-30份、艾叶8-20份、霸王鞭5-15份、刺蓼8-16份、古山龙5-15份,所述B方至少由以下重量份的原料组成:硫磺5-15份、枯矾5-15份、信石3-8份、薄荷脑5-20份。
所述A方至少由以下重量份的原料组成:金银花根28-36份、苦参18-25份、蛇床子12-18份、白及17-24份、艾叶10-16份、霸王鞭6-13份、刺蓼8-14份、古山龙7-12份,所述B方至少由以下重量份的原料组成:硫磺6-13份、枯矾5-10份、信石3-6份、薄荷脑5-18份。
所述A方至少由以下重量份的原料组成:金银花根31份、苦参19份、蛇床子14份、白及19份、艾叶13份、霸王鞭9份、刺蓼11份、古山龙8份,所述B方至少由以下重量份的原料组成:硫磺9份、枯矾7份、信石3份、薄荷脑14份。
所述A方至少由以下重量份的原料组成:金银花根33份、苦参20份、蛇床子12份、白及19份、艾叶15份、霸王鞭11份、刺蓼9份、古山龙11份,所述B方至少由以下重量份的原料组成:硫磺10份、枯矾5份、信石5份、薄荷脑17份。
本发明的第二方面提供了上述用于治疗皮肤瘙痒的药膏的制备方法,包括以下步骤:
步骤一:按配方量称取A方与B方的原料,分别放置备用;
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水蒸煮0.5-1.0h后,过滤得到药渣和药液A;
步骤四:在压力容器中将药渣与水混合,蒸煮0.5-1.0h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
步骤三中,蒸煮前压力容器内的物料固液比为1:5-8,蒸煮过程中,压力容器内水的沸点为115-125℃。
步骤四中,蒸煮前压力容器内的物料固液比为1:4-6,蒸煮过程中,压力容器内水的沸点为115-125℃。
步骤六中,药粉的粒径为研磨至不大于180目,且95%的药粉粒径小于200目。
实施例1:
步骤一:称取金银花根31份、苦参19份、蛇床子14份、白及19份、艾叶13份、霸王鞭9份、刺蓼11份、古山龙8份、硫磺9份、枯矾7份、信石3份、薄荷脑14份。
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水至固液比为1:6,120℃蒸煮0.8h后,过滤得到药渣和药液A;
步骤四:在压力容器中将固液比为1:4的药渣与水混合,115℃蒸煮0.6h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
实施例2:
步骤一:称取金银花根33份、苦参20份、蛇床子12份、白及19份、艾叶15份、霸王鞭11份、刺蓼9份、古山龙11份、硫磺10份、枯矾5份、信石5份、薄荷脑17份。
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水至固液比为1:6,120℃蒸煮0.8h后,过滤得到药渣和药液A;
步骤四:在压力容器中将固液比为1:4的药渣与水混合,115℃蒸煮0.6h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
实施例3:
步骤一:称取金银花根32份、苦参19份、蛇床子16份、白及21份、艾叶13份、霸王鞭8份、刺蓼12份、古山龙7份、硫磺7份、枯矾7份、信石4份、薄荷脑16份。
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水至固液比为1:6,120℃蒸煮0.8h后,过滤得到药渣和药液A;
步骤四:在压力容器中将固液比为1:4的药渣与水混合,115℃蒸煮0.6h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
对比例1:
本对比例与实施例1的不同之处在于,配方中未添加金银花根、苦参、蛇床子、硫磺。
对比例2:
本对比例与实施例1的不同之处在于,配方中未添加白及、艾叶、霸王鞭、枯矾。
对比例3:
本对比例与实施例1的不同之处在于,配方中未添加刺蓼、古山龙、信石。
对比例4:
本对比例为市售的某款用于皮肤瘙痒的药膏。
对比例5:
本对比例为市售的某款用于皮肤瘙痒的药膏。
药效试验:
试验对象:选取800位患有银屑病(牛皮癣)、神经皮炎(扁平苔藓)、体癣等会引发皮肤瘙痒症状的皮肤病患者,800位患者中,年龄分布平均,性别比例为1:1,将800位患者平均分为八组,每组对应分发实施例1-3及对比例1-5所提供的药膏。
止痒测试:
患者将对应的药膏涂抹至自身瘙痒处,对药膏的止痒效果进行评价打分,打分分值为0-5分,其中0分表示无效,5分表示效果最佳,8款药膏的平均得分见表1:
组别 | 实施例1 | 实施例2 | 实施例3 | 对比例1 |
得分 | 4.5 | 4.4 | 4.5 | 3.5 |
组别 | 对比例2 | 对比例3 | 对比例4 | 对比例5 |
得分 | 3.3 | 3.1 | 4.3 | 4.1 |
表1
由表1可知,本发明各实施例所提供的药膏,在止痒方面均具有良好的效果,通过通过对比观察对比例1-3的得分可知,缩减配方成分所制得的药膏,其止痒效果明显降低。
疗效测试:
患者每日两次于早晚对患处进行清洁后上药,每7天为一个疗程,持续4个疗程,对患者的病情进行观察,并做疗效判断,判断标准为:
痊愈:皮损全部消退,仅有色素沉着或消失;
显效:皮损消退70%以上;
有效:皮损消退30-70%之间;
无效:皮损消退30%以下或者病情更加严重。
各药膏的测试结果见表2:
表2
根据表2数据可知,本发明中,实施例1-3所提供的药膏,对于银屑病、神经皮炎、体癣等皮肤病均有不俗的疗效,四个疗程后,整体痊愈率较高,无效率低,而对实施例1的配方进行删减后的对比例1-3所提供的药膏,其虽然也具备一定的疗效,但药效明显下降,无效率上升明显,但对比市售的两款药膏,其疗效仍存在优势。
复发率随访调查:
对经四个疗程所治愈的患者中,每组随机抽选20位,于停药后6、12、18、24个月进行四次随访,询问瘙痒复发率,并进行统计,统计结果见表3:
表3
观察表3可知,本发明实施例1-3所提供的膏药,在治愈后,其复发率普遍较低,而对其配方成分进行缩减后的对比例1-3,其复发率明显提升,但整体而言,仍低于市售的两款膏药。
尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种用于治疗皮肤瘙痒的药膏,其特征在于:由A方、B方与鸸鹋油组成,所述A方至少由以下原料组成:金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙,所述B方至少由以下原料组成:硫磺、枯矾、信石、薄荷脑。
2.根据权利要求1所述的一种用于治疗皮肤瘙痒的药膏,其特征在于:所述A方至少由以下重量份的原料组成:金银花根25-40份、苦参15-30份、蛇床子10-20份、白及15-30份、艾叶8-20份、霸王鞭5-15份、刺蓼8-16份、古山龙5-15份,所述B方至少由以下重量份的原料组成:硫磺5-15份、枯矾5-15份、信石3-8份、薄荷脑5-20份。
3.根据权利要求1所述的一种用于治疗皮肤瘙痒的药膏,其特征在于:所述A方至少由以下重量份的原料组成:金银花根28-36份、苦参18-25份、蛇床子12-18份、白及17-24份、艾叶10-16份、霸王鞭6-13份、刺蓼8-14份、古山龙7-12份,所述B方至少由以下重量份的原料组成:硫磺6-13份、枯矾5-10份、信石3-6份、薄荷脑5-18份。
4.根据权利要求1所述的一种用于治疗皮肤瘙痒的药膏,其特征在于:所述A方至少由以下重量份的原料组成:金银花根31份、苦参19份、蛇床子14份、白及19份、艾叶13份、霸王鞭9份、刺蓼11份、古山龙8份,所述B方至少由以下重量份的原料组成:硫磺9份、枯矾7份、信石3份、薄荷脑14份。
5.根据权利要求1所述的一种用于治疗皮肤瘙痒的药膏,其特征在于:所述A方至少由以下重量份的原料组成:金银花根33份、苦参20份、蛇床子12份、白及19份、艾叶15份、霸王鞭11份、刺蓼9份、古山龙11份,所述B方至少由以下重量份的原料组成:硫磺10份、枯矾5份、信石5份、薄荷脑17份。
6.根据权利要求1-5中任一所述的一种用于治疗皮肤瘙痒的药膏的制备方法,其特征在于:包括以下步骤:
步骤一:按配方量称取A方与B方的原料,分别放置备用;
步骤二:将金银花根、苦参、蛇床子、白及、艾叶、霸王鞭、刺蓼、古山龙洗净晾干后,裁碎成长度小于1cm的药材碎片;
步骤三:将药材碎片放入压力容器中,加水蒸煮0.5-1.0h后,过滤得到药渣和药液A;
步骤四:在压力容器中将药渣与水混合,蒸煮0.5-1.0h后,过滤的药液B;
步骤五:将药液A与药液B混合,离心静置后取上清液备用;
步骤六:将硫磺、枯矾、信石、薄荷脑洗净干燥后,破碎研磨过筛,得到药粉;
步骤七:将药粉与上清液均匀混合后,减压浓缩,得到混合膏;
步骤八:取适量鸸鹋油与混合膏进行混合,得到稠度适当的药膏。
7.根据权利要求6所述的一种用于治疗皮肤瘙痒的药膏的制备方法,其特征在于:步骤三中,蒸煮前压力容器内的物料固液比为1:5-8,蒸煮过程中,压力容器内水的沸点为115-125℃。
8.根据权利要求6所述的一种用于治疗皮肤瘙痒的药膏的制备方法,其特征在于:步骤四中,蒸煮前压力容器内的物料固液比为1:4-6,蒸煮过程中,压力容器内水的沸点为115-125℃。
9.根据权利要求6所述的一种用于治疗皮肤瘙痒的药膏的制备方法,其特征在于:步骤六中,药粉的粒径为研磨至不大于180目,且95%的药粉粒径小于200目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110665243.7A CN113456755A (zh) | 2021-06-16 | 2021-06-16 | 一种用于治疗皮肤瘙痒的药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110665243.7A CN113456755A (zh) | 2021-06-16 | 2021-06-16 | 一种用于治疗皮肤瘙痒的药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113456755A true CN113456755A (zh) | 2021-10-01 |
Family
ID=77870107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110665243.7A Pending CN113456755A (zh) | 2021-06-16 | 2021-06-16 | 一种用于治疗皮肤瘙痒的药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113456755A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130534A (zh) * | 1995-03-08 | 1996-09-11 | 朱海峰 | 一种药物卫生棒 |
CN101259183A (zh) * | 2008-04-29 | 2008-09-10 | 李仲甫 | 一种治疗瘙痒性皮肤病的外用中草药及其制备方法 |
CN102579827A (zh) * | 2012-03-01 | 2012-07-18 | 王子肖 | 治疗足癣的药物的制备方法 |
CN102861271A (zh) * | 2012-10-09 | 2013-01-09 | 中国人民解放军第四军医大学 | 外用消炎止痒软膏制剂及其制备方法 |
CN104383067A (zh) * | 2014-12-05 | 2015-03-04 | 陕西去病药业有限公司 | 治疗各类癣症和皮肤瘙痒症的中药制剂及其制备方法 |
CN112618463A (zh) * | 2021-01-19 | 2021-04-09 | 北京圣永制药有限公司 | 一种含有中药提取物的抑菌护肤沐浴液 |
-
2021
- 2021-06-16 CN CN202110665243.7A patent/CN113456755A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130534A (zh) * | 1995-03-08 | 1996-09-11 | 朱海峰 | 一种药物卫生棒 |
CN101259183A (zh) * | 2008-04-29 | 2008-09-10 | 李仲甫 | 一种治疗瘙痒性皮肤病的外用中草药及其制备方法 |
CN102579827A (zh) * | 2012-03-01 | 2012-07-18 | 王子肖 | 治疗足癣的药物的制备方法 |
CN102861271A (zh) * | 2012-10-09 | 2013-01-09 | 中国人民解放军第四军医大学 | 外用消炎止痒软膏制剂及其制备方法 |
CN104383067A (zh) * | 2014-12-05 | 2015-03-04 | 陕西去病药业有限公司 | 治疗各类癣症和皮肤瘙痒症的中药制剂及其制备方法 |
CN112618463A (zh) * | 2021-01-19 | 2021-04-09 | 北京圣永制药有限公司 | 一种含有中药提取物的抑菌护肤沐浴液 |
Non-Patent Citations (3)
Title |
---|
叶金玲;等: "鸸鹋油的应用研究进展", 经济动物学报, vol. 23, no. 04, pages 242 * |
王廷栋;: "湿疹散治疗急慢性湿疹", 中国临床医生, no. 11, pages 1 * |
高淑华;等: "苦黄药水外用治疗五种皮肤病200例疗效观察", 长治医学院学报, vol. 16, no. 02, pages 145 - 146 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105477487A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN110840955A (zh) | 一种治疗鼻炎的中药及其制备方法 | |
CN103055218B (zh) | 用于治疗新生儿黄疸的中药组合物及其制备方法 | |
CN103263654B (zh) | 一种治疗大叶性肺炎的药物及其制备方法 | |
CN104758900A (zh) | 一种用于治疗急性胰腺炎的中药 | |
CN103417911A (zh) | 化疗辅助用中药组合物 | |
CN113456755A (zh) | 一种用于治疗皮肤瘙痒的药膏及其制备方法 | |
CN105561098A (zh) | 一种治疗糜烂性脚气的药物 | |
CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
CN107823303B (zh) | 一种治疗痔疮的壮医外用熏洗汤 | |
CN105412596A (zh) | 一种治疗肝肿瘤的中药组合物及其制备方法 | |
CN111632080A (zh) | 一种治疗药疹皮炎的配方及制备方法及应用 | |
CN105031310A (zh) | 一种治疗风寒湿痹的药物及其制备方法 | |
CN110585286A (zh) | 一种治疗皮肤疾病的外用药膏及其制备方法 | |
CN111494571B (zh) | 一种治疗湿热痹阻型痛风的中药组合物及其制备方法 | |
CN113425777A (zh) | 一种用于治疗神经性皮炎的药膏及其制备方法 | |
CN108273009B (zh) | 一种治疗尖锐湿疣的中药丸剂 | |
CN106474448A (zh) | 一种治疗时行感冒的药物及其制备方法 | |
CN113769041A (zh) | 一种用于治疗妇科炎症的外用中药组合物及其制备方法 | |
CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN105079425A (zh) | 一种治疗小儿手足口病的组合物制剂及其制备方法 | |
CN105012789A (zh) | 治疗宫颈癌的组合物及其制备方法 | |
CN115845010A (zh) | 一种治疗扁平疣的中药组合物及其制备方法 | |
CN104758757A (zh) | 一种治疗足癣的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |